News Flerie Invest AB

Equities

FLERIE

SE0008966295

Delayed Nasdaq Stockholm Other stock markets 06:40:10 27/06/2024 pm IST			5-day change	1st Jan Change
0.476 ^SEK	-0.83%		-4.61%	+87.50%

14/06	Alligator Bioscience Names New CFO	MT
13/06	InDex Pharmaceuticals Holding AB will Change its Name to Flerie AB	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Alligator Bioscience Names New CFO	14/06	MT
InDex Pharmaceuticals Holding AB will Change its Name to Flerie AB	13/06	CI
InDex Pharmaceuticals completes reverse merger with Flerie	10/06	AQ
Bulletin from the Extraordinary General Meetings in InDex Pharmaceuticals Holding AB (publ) on June 10, 2024	10/06	AQ
Flerie Invest AB completed the acquisition of InDex Pharmaceuticals Holding AB (OM:INDEX) from group of shareholders.	10/06	CI
InDex Pharmaceuticals Gets OK to Keep Nasdaq First North Growth Market Listing Amid Reverse Takeover, Uplisting Plans	07/06	MT
InDex Pharmaceuticals has received a conditional approval for continued listing on Nasdaq First North Growth Market after the reverse merger of Flerie	07/06	AQ
InDex Pharmaceuticals publishes NAV for Flerie as of May 31, 2024	04/06	AQ
InDex Pharmaceuticals publishes company description in connection with the reverse merger of Flerie	27/05	AQ
Flerie makes its way to the stock market via InDex	23/05	AQ
Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson...	21/05
InDex Pharmaceuticals to Buy Flerie Invest Under Reverse Merger Plan	21/05	MT
InDex Pharmaceuticals has entered into a conditional agreement regarding a reverse merger with Flerie	21/05	AQ
Bulletin from the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)	07/05	AQ
InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member	07/05	CI
Notice of extraordinary general meeting in InDex Pharmaceuticals Holding AB (publ)	07/05	AQ
InDex Pharmaceuticals provides a status update and informs about Extraordinary General Meeting on June 10, 2024	07/05	AQ
InDex Pharmaceuticals Holding AB (publ) interim report January - March 2024	26/04	AQ
InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
InDex Pharmaceuticals brings forward the publication of the interim report for Q1 2024	22/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Flerie Invest AB

Equities

FLERIE

SE0008966295

Summary

Filters